Background: The prognostic relevance of left atrial (LA) morphological and functional variables,
| I N TR ODU C TI ON
Myxomatous mitral valve disease (MMVD) is the most common cardiac disease in dogs, with a prevalence of > 75% in individuals of specific canine breeds > 5 years of age. 1, 2 In dogs weighing < 9 kg, the most important cause of death is cardiac-related. 3 Therefore, the study of prognostic indicators of mortality in this population of animals is of primary importance. Several studies have focused on evaluating clinical and echocardiographic variables that may predict cardiac mortality in dogs with MMVD. [4] [5] [6] [7] Because echocardiography is the most commonly used diagnostic test in assessing dogs with cardiac disease, it is also the most studied technique for stratification of dogs with cardiac disease.
Different Doppler variables, two-dimensional (2D) echocardiographic
indicators of mitral valve (MV) pathology, and degree of left atrial (LA) dilatation are strong predictors of cardiac-related death in dogs with MMVD. 4, 5, 8 In particular, LA size is easy to measure and strongly associated with negative prognosis in affected dogs. 4, 5, 8 Left atrial dimension can be assessed using different echocardiographic methods, 9-11 but a recent study has shown that bi-planarderived LA volume is superior to traditional simple LA diameter in predicting LA dilatation in dogs with MMVD. 12 Until now, survival studies have considered only LA diameter and its ratio to aortic root diameter (Ao; [LA/Ao]) as predictors of survival. [4] [5] [6] Canine and feline LA function has been non-invasively estimated with echocardiography using several approaches, such as measuring LA fractional shortening, LA fractional area change (FAC), and LA ejection fraction (EF). [13] [14] [15] [16] Assessment of atrial deformation profiles obtained using tissue Doppler imaging (TDI) and its derived variables, strain and strain rate, recently has been proposed as an alternative method of exploring LA mechanics both in humans [17] [18] [19] and dogs. 20 Nevertheless, a number of potential drawbacks of this approach should be considered, including suboptimal reproducibility, angle dependence, and the confounding effect of noise artifacts. [17] [18] [19] [20] Many of these limitations may be overcome by using 2D speckle tracking echocardiography (STE), the most recent and promising ultrasound technology for direct evaluation of LA function from standard gray-scale echocardiographic images. [17] [18] [19] Until now, only a few studies have used STE in evaluating LA function both in healthy 21 and diseased dogs, 15, 22 highlighting a progressive decrease in LA function according to the progression of MMVD class. Decreased LA function also has been recognized as a valuable prognostic indicator in dogs with MMVD. 23 However, studies comparing different echocardiographic variables, particularly those of LA dimension and function, as predictors of cardiac mortality in dogs with MMVD are lacking.
Therefore, the aims of our study were: (1) The same cine-loops and beats used to measure LA areas and volumes were successively employed for the STE analysis using dedicated software (QLAB quantification software version 9.1, Philips Healthcare, Monza, Italy.) as previously described. 15 Briefly, the operator selected 3 points on the LA (2 on the MV annulus and 1 on the LA roof) and the software automatically drew a region of interest on the entire LA wall dividing it into 7 regions (from the basilar segments to the roof of the LA), and manual editing was done if necessary. Those segments that
showed artifactual values (because of the lung interposition or echo drop-out at the level of the region of the fossa ovalis or the pulmonary veins inlet) were excluded from the analysis. Time/intensity curves then were generated for each segment displacing strain values (as percentages) on the y-axis and time (in seconds) on the x-axis over an entire cardiac cycle. The software also generated a mean curve of all the segments that was used by the operator to measure the peak strain value during LV contraction (peak atrial longitudinal strain [PALS]), and just before LA active contraction, on the peak of the P wave of the ECG trace (peak atrial contraction strain [PACS]). Finally, the contraction strain index (CSI) was calculated using the formula: CSI 5 ([PALS/ PACS] 3 100; Figure 1 ). This last variable represents the contribution of LA contraction to LV filling. 15 The entire image analysis was per- 
| Survival analysis
Survival data were obtained from an internal database or by telephone questionnaires. Dogs were classified as still alive, dead for cardiacunrelated causes, or dead for cardiac-related causes (defined as sudden death, CHF refractory to medical treatment, euthanasia because of worsening cardiac condition, or death within 2 hours from the onset of pulmonary edema). 4 Time in days from the echocardiographic examination to the phone call for dogs still alive (follow-up time) or to death (survival time) was recorded.
| Statistical analysis
Descriptive statistics were used for age, sex, and BW. Normal distribution of the echocardiographic, echo-Doppler, and STE-derived variables was assessed using a Shapiro-Wilks test. Data were reported as The approach used to analyze days of survival after diagnosis was that previously reported. 8 Measurements of all STE variables (PALS, PACS, CSI, LAAmax, LAAmin, and FAC) previously had shown good intraobserver and interobserver repeatability in our laboratory. 15 Because LA volumes were directly derived from LA areas measurements, variability analysis of these variables was not performed.
| R E SU LTS
One-hundred fifteen dogs met the inclusion criteria of the study.
Descriptive statistics and echocardiographic variables are summarized in Table 3 ). The Kaplan-Meier curves for the variables that were significant in the multivariable analysis are presented in Figure 2 .
| D ISC USSION
We evaluated the prognostic value of several echocardiographic variables on survival in dogs with MMVD. In particular, we focused on LA morphological and functional variables, also including for the first time in veterinary medicine some STE-derived variables.
The survival analysis showed that STE-derived LA strain and the Moreover, increasing MV E vel values over serial examinations also have been associated with a poorer outcome. 27 Mitral valve E vel is determined mainly by LV filling pressures and relaxation. 28 In cardiac disease, such as MMVD, where the preload is disproportionally increased, the filling pressure component is dominant on relaxation.
Therefore, an increase in MV E vel is an indirect measure of mitral regurgitation severity, reflecting worsening pressure differences between the LA and LV with increasing regurgitant volumes. 8, 28 Not surprisingly, the 2 variables that better reflect increased LA preload,
namely MV E vel and LAVmax, were both predictors of cardiac death in the multivariable analysis.
Regarding LA measurement, LA/Ao was an independent predictor of a poor prognosis in the first study on clinical and echocardiographic predictors of mortality in dogs with MMVD, 4 but this finding was not confirmed in a more recent study. Data are expressed as mean 6 SD or median (min-max). Abbreviations: CHF, congestive heart failure; CKCS, Cavalier king Charles spaniel; CSI, contraction strain index; LA/Ao, left atrial diameter to aorta ratio; LAEi, left atrial expansion index; LA FAC, left atrial fractional area change; LAAmax/Ao, left atrial maximal area to aortic area ratio; LAAmin/Ao, left atrial minimal area to aortic area ratio; LAVmax, left atrial maximal volume indexed to body weight; LAVmin, left atrial minimal volume indexed to body weight; LVIDd/Ao, left ventricular internal dimension in diastole to aorta ratio; LVIDs/Ao, left ventricular internal dimension in systole to aorta ratio; MV E vel, mitral valve E wave peak velocity; N, number of dogs; PALS, peak atrial longitudinal strain; PACS, peak atrial contraction strain a Reported as mean (95th percentile).
been proven to predict cardiac-related death in dogs with MMVD, 4 the volumetric approach of measuring the LA seems more effective in predicting mortality. In humans, presence of LA dilatation correlates with increased risk of developing stroke, atrial fibrillation, and cardiac-related death. 29 Therefore, detecting cardiac chamber dilatation is crucial for stratifying patients with cardiac disease, and the recommended way to assess LA dilatation in people now is the use of volumetric methods. 30 In cats with cardiac disease, LA volume and LA EF, obtained from volume measurement over the cardiac cycle, have been reported to be useful diagnostic and prognostic echocardiographic variables, showing better performance when compared to simple diameter measurements. 31 One study comparing LA/Ao with LA volume assessment in a population of dogs with MMVD showed that mild LA dilatation could be detected in some dogs only by measuring LA volume, but not LA diameter. 12 Results of our study confirm that the use of a volumetric method also has prognostic relevance in assessing LA dimension in dogs compared to standard linear measurement. Whether this kind of measurement is reproducible among different cardiologists at different centers still must be clearly elucidated. At present, studies from 2 different research groups have shown acceptable reproducibility in assessing LA volumes both in healthy dogs 10, 13 and dogs with MMVD.
11
Among the variables of LA function, only STE-derived variables were predictors of cardiac related death in our population of dogs, whereas LA FAC and LAEi were not ( Figure 2 ). This finding is in contrast with a previous study where LA FAC appeared to be a prognostic factor within 1 year in dogs with MMVD. 23 In that study, a different type of statistical analysis was carried out, with a direct comparison of LA FAC values between dogs that were dead or alive at 1 year after inclusion. In our study, STE-derived PALS, PACS, and CSI were all univariate predictors of survival. Left atrial strain recently has been studied to validate the technique in clinically healthy dogs 21 and to evaluate strain changes in dogs under experimental conditions, 32, 33 or in dogs with naturally occurring MMVD. 15, 22 With progression of disease, STEderived variables tend to decrease as a consequence of progressive impairment in LA contraction and relaxation. 15, 22 This might be secondary to changes in loading conditions, LA preload and afterload, and progressive LA fibrosis that occur during MMVD. 15, 34 In people, LA strain analysis is useful for stratifying patients with valvular disease, atrial fibrillation, or acute coronary disease. [35] [36] [37] Moreover, LA strain has been shown to be an independent predictor of death or the need for cardiac transplantation in people with symptomatic systolic dysfunction. 38 Our study is the first in veterinary medicine to show that, similarly to people, STE-derived strain can be used as a prognostic indicator also in dogs with cardiac disease, namely MMVD.
Our study had some limitations. We focused mainly on echocardiographic indicators of LA morphology and function, without introducing echocardiographic variables of MV pathology into the analysis, the radiographically derived vertebral heart score, or clinical variables, such as syncope, presence of heart murmur, presence of CHF, and dyspnea, that are known to be independent prognostic indicators in dogs with MMVD. 4, 7, 8, 39 Moreover, for the assessment of LA volume we used the monoplane area-length method obtained from the 4-chamber view.
In people, the bi-plane method from the 4-and 2-chamber views is preferred to derive LA volumes. 30 However, studies in dogs have
shown that use of a monoplane method overestimates the volume by only 5.8% when compared with the bi-plane method. 11 Moreover, a strong correlation exists among different methods of calculation of LA volumes in dogs when using 2D echocardiographic images. 10, 11 Therefore, different echocardiographic approaches in measuring LA volumes in dogs appear interchangeable in the clinical setting, and it appears unlikely that the method we chose negatively affected our results.
Another possible limitation to our study is the use of a single cardiac cycle to perform the STE analysis. Whether the beat-to-beat variation and sinus arrhythmia could significantly affect LA STE-derived variables in dogs remains to be elucidated in further studies. Finally, the effect of cardiac medication and diuretics on LA function and STE-derived variables has not been investigated. In clinically healthy dogs, experimentally induced volume overload enhances LA phasic function because of the increased preload, according to the Frank-Starling mechanism. 32 However, in naturally occurring disease, LA phasic function decreases with the progression of the disease, likely in response to the presence of other concurrent mechanisms, such as increased LA afterload and LA fibrosis. 15 It might be speculated that using some medications that decrease LA pressure (eg, furosemide, angiotensin converting enzyme inhibitors, amlodipine, pimobendan) [39] [40] [41] [42] [43] could have an effect on LA function, leading to some bias when comparing untreated dogs with LA dilatation and dogs under medical treatment. To prove whether or not this assumption is correct requires further studies.
In conclusion, we evaluated the prognostic significance of several 
